Franck Lach

Discovery of a Potent, Selective, Orally Bioavailable, and Efficacious Novel 2-(Pyrazol-4-ylamino)-pyrimidine Inhibitor of the Insulin-like Growth Factor-1 Receptor (IGF-1R).

Scott Boyd, S. Degorce, R. Ducray, 2016, Journal of medicinal chemistry.